Forteris Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47M Sell
2,062
-35
-2% -$35.8K 2.02% 18
2026
Q1
$1.93M Sell
2,097
-373
-15% -$378K 1.85% 20
2025
Q4
$2.65M Buy
+2,470
New +$2.36M 2.61% 15

Other funds holding LLY

Forteris Wealth Management's LLY Position: Q2 2026 in Review

Forteris Wealth Management reduced its Eli Lilly (LLY) stake by 1.7% in Q2 2026, selling an estimated $35.8K and leaving 2,062 shares worth $2.47M. The position accounts for 2.02% of the portfolio, ranked #18.

Forteris Wealth Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.65M in Q4 2025. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Forteris Wealth Management held 2,062 shares of Eli Lilly worth $2.47M as of Q2 2026.
  • Forteris Wealth Management sold 35 Eli Lilly shares in Q2 2026, an estimated $35.8K.
  • Eli Lilly made up 2.02% of Forteris Wealth Management's portfolio in Q2 2026, its #18 holding.
  • Forteris Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Forteris Wealth Management's Eli Lilly position peaked at $2.65M in Q4 2025.
  • 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Forteris Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.